FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017457570> ?p ?o ?g. }

• W2017457570 endingPage "328" @default.
• W2017457570 startingPage "314" @default.
• W2017457570 abstract "The aim of this study was to compare the efficacy and safety of once daily dosing with moxifloxacin (BAY 12-8039) with that of coamoxiclav given three times daily for the treatment of acute exacerbation of chronic bronchitis (AECB). Moxifloxacin (one 400 mg tablet daily) was administered orally for 5 days and co-amoxiclav (three 625 mg tablets daily) was given orally for 7 days. The study was randomized, non-blinded, multinational (12 countries) and multicentre (68 centres). A total of 575 patients, all with clear signs of AECB, were treated, 292 with moxifloxacin and 283 with co-amoxiclav. Of these, 512 patients were evaluable for efficacy (261 in the moxifloxacin group and 251 in the co-amoxiclav group). The primary efficacy parameter was clinical response at 14 days in the evaluable population. A clinical success was classified as resolution or improvement of symptoms. Variables used to assess clinical response included wheeze, cough, dyspnoea, sputum volume, rales and rhonchi. The success rate for moxifloxacin in the evaluable patients was 96.2% and that for co-amoxiclav was 91.6%. The 95% confidence intervals for this difference (0.4%; 8.7%) indicate equivalence in the treatments. Sputum samples were taken from patients and 140 of these contained a pathogen, Haemophilus influenzae being the most frequently isolated. Moraxella catarrhalis and Streptococcus pneumoniae were also commonly isolated pathogens. The eradication rate at 14 days in the evaluable patients was 87.7% in the moxifloxacin group and 89.6% in the coamoxiclav group. Both drugs were well tolerated with no significant differences in the numbers of drug-related adverse events or the numbers of patients withdrawing because of an adverse event. These results and the broad spectrum of antibacterial activity make moxifloxacin a promising and safe alternative to conventional therapy for the empirical treatment of AECB." @default.
• W2017457570 created "2016-06-24" @default.
• W2017457570 creator A5001408264 @default.
• W2017457570 creator A5007724854 @default.
• W2017457570 creator A5014405562 @default.
• W2017457570 creator A5026303511 @default.
• W2017457570 creator A5034768543 @default.
• W2017457570 creator A5087043342 @default.
• W2017457570 date "2001-08-01" @default.
• W2017457570 modified "2023-10-18" @default.
• W2017457570 title "A Multinational, Multicentre, Non-Blinded, Randomized Study of Moxifloxacin Oral Tablets Compared with Co-Amoxiclav Oral Tablets in the Treatment of Acute Exacerbation of Chronic Bronchitis" @default.
• W2017457570 cites W1969499889 @default.
• W2017457570 cites W1989595510 @default.
• W2017457570 cites W1990494173 @default.
• W2017457570 cites W2005289893 @default.
• W2017457570 cites W2005334676 @default.
• W2017457570 cites W2012519534 @default.
• W2017457570 cites W2026393688 @default.
• W2017457570 cites W2089313705 @default.
• W2017457570 cites W2101718295 @default.
• W2017457570 cites W2103356254 @default.
• W2017457570 cites W2115141652 @default.
• W2017457570 cites W2128954866 @default.
• W2017457570 cites W2131257192 @default.
• W2017457570 cites W2146550683 @default.
• W2017457570 cites W2149144558 @default.
• W2017457570 cites W2156418135 @default.
• W2017457570 cites W2161455128 @default.
• W2017457570 cites W2164228218 @default.
• W2017457570 cites W2773439835 @default.
• W2017457570 cites W4254841797 @default.
• W2017457570 doi "https://doi.org/10.1177/147323000102900408" @default.
• W2017457570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11675905" @default.
• W2017457570 hasPublicationYear "2001" @default.
• W2017457570 type Work @default.
• W2017457570 sameAs 2017457570 @default.
• W2017457570 citedByCount "50" @default.
• W2017457570 countsByYear W20174575702012 @default.
• W2017457570 countsByYear W20174575702014 @default.
• W2017457570 countsByYear W20174575702017 @default.
• W2017457570 countsByYear W20174575702018 @default.
• W2017457570 crossrefType "journal-article" @default.
• W2017457570 hasAuthorship W2017457570A5001408264 @default.
• W2017457570 hasAuthorship W2017457570A5007724854 @default.
• W2017457570 hasAuthorship W2017457570A5014405562 @default.
• W2017457570 hasAuthorship W2017457570A5026303511 @default.
• W2017457570 hasAuthorship W2017457570A5034768543 @default.
• W2017457570 hasAuthorship W2017457570A5087043342 @default.
• W2017457570 hasConcept C126322002 @default.
• W2017457570 hasConcept C142724271 @default.
• W2017457570 hasConcept C2776301714 @default.
• W2017457570 hasConcept C2777014857 @default.
• W2017457570 hasConcept C2778836808 @default.
• W2017457570 hasConcept C2779993553 @default.
• W2017457570 hasConcept C2781069245 @default.
• W2017457570 hasConcept C2908647359 @default.
• W2017457570 hasConcept C2992694001 @default.
• W2017457570 hasConcept C501593827 @default.
• W2017457570 hasConcept C71924100 @default.
• W2017457570 hasConcept C86803240 @default.
• W2017457570 hasConcept C89423630 @default.
• W2017457570 hasConcept C99454951 @default.
• W2017457570 hasConceptScore W2017457570C126322002 @default.
• W2017457570 hasConceptScore W2017457570C142724271 @default.
• W2017457570 hasConceptScore W2017457570C2776301714 @default.
• W2017457570 hasConceptScore W2017457570C2777014857 @default.
• W2017457570 hasConceptScore W2017457570C2778836808 @default.
• W2017457570 hasConceptScore W2017457570C2779993553 @default.
• W2017457570 hasConceptScore W2017457570C2781069245 @default.
• W2017457570 hasConceptScore W2017457570C2908647359 @default.
• W2017457570 hasConceptScore W2017457570C2992694001 @default.
• W2017457570 hasConceptScore W2017457570C501593827 @default.
• W2017457570 hasConceptScore W2017457570C71924100 @default.
• W2017457570 hasConceptScore W2017457570C86803240 @default.
• W2017457570 hasConceptScore W2017457570C89423630 @default.
• W2017457570 hasConceptScore W2017457570C99454951 @default.
• W2017457570 hasIssue "4" @default.
• W2017457570 hasLocation W20174575701 @default.
• W2017457570 hasLocation W20174575702 @default.
• W2017457570 hasOpenAccess W2017457570 @default.
• W2017457570 hasPrimaryLocation W20174575701 @default.
• W2017457570 hasRelatedWork W1966506194 @default.
• W2017457570 hasRelatedWork W2010160388 @default.
• W2017457570 hasRelatedWork W2059086374 @default.
• W2017457570 hasRelatedWork W2297753313 @default.
• W2017457570 hasRelatedWork W2387874083 @default.
• W2017457570 hasRelatedWork W2404968759 @default.
• W2017457570 hasRelatedWork W2416459860 @default.
• W2017457570 hasRelatedWork W2416587185 @default.
• W2017457570 hasRelatedWork W2441507987 @default.
• W2017457570 hasRelatedWork W2562646555 @default.
• W2017457570 hasVolume "29" @default.
• W2017457570 isParatext "false" @default.
• W2017457570 isRetracted "false" @default.
• W2017457570 magId "2017457570" @default.
• W2017457570 workType "article" @default.